Regeneus Ltd (ASX: RGS) is an Australian clinical-stage regenerative medicine company developing a portfolio of innovative cellular therapies targeting significant unmet medical needs with a licence driven strategy.
Our Latest Articles on Regeneus
|Article||02-Mar-2020||Can This ASX Junior Surge Through the Pain Barrier?|
Can This ASX Junior Surge Through the Pain Barrier?
Mar 2, 2020
Biotech company Regeneus (ASX:RGS) is a regenerative medicine company, and the therapy is a novel stem cell therapy.